DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
151.85
+4.31 (2.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
DaVita Revenue
DaVita had revenue of $3.26B in the quarter ending September 30, 2024, with 4.56% growth. This brings the company's revenue in the last twelve months to $12.67B, up 6.34% year-over-year. In the year 2023, DaVita had annual revenue of $12.14B with 4.57% growth.
Revenue (ttm)
$12.67B
Revenue Growth
+6.34%
P/S Ratio
1.05
Revenue / Employee
$180,952
Employees
70,000
Market Cap
12.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
| Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
| Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
| Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
| Dec 31, 2019 | 11.39B | -23.67M | -0.21% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tenet Healthcare | 20.97B |
| Universal Health Services | 15.42B |
| Solventum | 8.22B |
| Incyte | 4.08B |
| Dr. Reddy's Laboratories | 3.58B |
| Genmab | 2.97B |
| BioMarin Pharmaceutical | 2.75B |
| Sarepta Therapeutics | 1.64B |
DVA News
- 5 weeks ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 5 weeks ago - DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PRNewsWire
- 6 weeks ago - DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - PRNewsWire
- 7 weeks ago - DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - DaVita misses third-quarter profit estimates on higher costs - Reuters
- 7 weeks ago - DaVita Inc. 3rd Quarter 2024 Results - PRNewsWire
- 7 weeks ago - DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program - PRNewsWire
- 2 months ago - DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 - PRNewsWire